Literature DB >> 19231761

CKD surveillance using laboratory data from the population-based National Health and Nutrition Examination Survey (NHANES).

Alejandro F Castro1, Josef Coresh.   

Abstract

Surveillance for chronic kidney disease (CKD) using nationally representative samples of the US population is central in providing information about the magnitude and trends in CKD burden that will guide disease management and prevention planning for clinicians and public health authorities. We used a cross-sectional study design to estimate the change in prevalence of CKD over time by using National Health and Nutrition Examination Survey (NHANES) data. NHANES III (1988-1994) included 15,488 participants and NHANES rounds 1999-2004 included 13,233 participants older than 20 years with serum creatinine measurements who were examined in a mobile examination center. Early stages of CKD were defined by glomerular filtration rate (GFR) estimated by using the Modification of Diet in Renal Disease (MDRD) Study equation and urinary albumin-creatinine ratio following the classification system established by the National Kidney Foundation's Kidney Disease Outcomes Quality Initiative. Moderately decreased GFR increased in prevalence from 5.4% to 7.7% (P < 0.001) and severely decreased GFR increased from 0.21% to 0.35% (P = 0.02) from 1988-1994 to 1999-2004. Within CKD stage 3, 18.6% +/- 1.6% (SE) of individuals should be referred to a nephrologist following a proposed set of criteria for referral; referral rates were highest for individuals with diabetes and lower in whites compared with other race-ethnicity groups. These survey data suggest that the prevalence of CKD has increased between 1988-1994 and 1999-2004. Surveillance for early stages of CKD (stages 1 to 4) should monitor these and other trends.

Entities:  

Mesh:

Year:  2009        PMID: 19231761      PMCID: PMC2677815          DOI: 10.1053/j.ajkd.2008.07.054

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  16 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001.

Authors:  Ali H Mokdad; Earl S Ford; Barbara A Bowman; William H Dietz; Frank Vinicor; Virginia S Bales; James S Marks
Journal:  JAMA       Date:  2003-01-01       Impact factor: 56.272

3.  Assessing kidney function--measured and estimated glomerular filtration rate.

Authors:  Lesley A Stevens; Josef Coresh; Tom Greene; Andrew S Levey
Journal:  N Engl J Med       Date:  2006-06-08       Impact factor: 91.245

4.  Mortality risk stratification in chronic kidney disease: one size for all ages?

Authors:  Ann M O'Hare; Daniel Bertenthal; Kenneth E Covinsky; C Seth Landefeld; Saunak Sen; Kala Mehta; Michael A Steinman; Ann Borzecki; Louise C Walter
Journal:  J Am Soc Nephrol       Date:  2006-02-01       Impact factor: 10.121

5.  Prevalence of chronic kidney disease in the United States.

Authors:  Josef Coresh; Elizabeth Selvin; Lesley A Stevens; Jane Manzi; John W Kusek; Paul Eggers; Frederick Van Lente; Andrew S Levey
Journal:  JAMA       Date:  2007-11-07       Impact factor: 56.272

6.  Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

Authors:  Ihab Hajjar; Theodore A Kotchen
Journal:  JAMA       Date:  2003-07-09       Impact factor: 56.272

7.  Age affects outcomes in chronic kidney disease.

Authors:  Ann M O'Hare; Andy I Choi; Daniel Bertenthal; Peter Bacchetti; Amit X Garg; James S Kaufman; Louise C Walter; Kala M Mehta; Michael A Steinman; Michael Allon; William M McClellan; C Seth Landefeld
Journal:  J Am Soc Nephrol       Date:  2007-09-12       Impact factor: 10.121

8.  Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004.

Authors:  Elizabeth Selvin; Jane Manzi; Lesley A Stevens; Frederick Van Lente; David A Lacher; Andrew S Levey; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2007-12       Impact factor: 8.860

Review 9.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

Authors:  Mark J Sarnak; Andrew S Levey; Anton C Schoolwerth; Josef Coresh; Bruce Culleton; L Lee Hamm; Peter A McCullough; Bertram L Kasiske; Ellie Kelepouris; Michael J Klag; Patrick Parfrey; Marc Pfeffer; Leopoldo Raij; David J Spinosa; Peter W Wilson
Journal:  Hypertension       Date:  2003-11       Impact factor: 10.190

10.  Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey.

Authors:  Josef Coresh; Brad C Astor; Tom Greene; Garabed Eknoyan; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2003-01       Impact factor: 8.860

View more
  32 in total

1.  High prevalence of and potential mechanisms for chronic kidney disease in patients with acute intermittent porphyria.

Authors:  Nicolas Pallet; Iadh Mami; Caroline Schmitt; Zoubida Karim; Arnaud François; Marion Rabant; Dominique Nochy; Laurent Gouya; Jean-Charles Deybach; Yichum Xu-Dubois; Eric Thervet; Hervé Puy; Alexandre Karras
Journal:  Kidney Int       Date:  2015-04-01       Impact factor: 10.612

2.  Arterial remodeling associates with CKD progression.

Authors:  Marie Briet; Cédric Collin; Alexandre Karras; Stéphane Laurent; Erwan Bozec; Christian Jacquot; Bénédicte Stengel; Pascal Houillier; Marc Froissart; Pierre Boutouyrie
Journal:  J Am Soc Nephrol       Date:  2011-04-14       Impact factor: 10.121

3.  Epidemiology and prognostic significance of chronic kidney disease in the elderly--the Three-City prospective cohort study.

Authors:  Benedicte Stengel; Marie Metzger; Marc Froissart; Muriel Rainfray; Claudine Berr; Christophe Tzourio; Catherine Helmer
Journal:  Nephrol Dial Transplant       Date:  2011-06-15       Impact factor: 5.992

Review 4.  Influence of race, ethnicity and socioeconomic status on kidney disease.

Authors:  Rachel E Patzer; William M McClellan
Journal:  Nat Rev Nephrol       Date:  2012-06-26       Impact factor: 28.314

5.  A nurse-coordinated model of care versus usual care for stage 3/4 chronic kidney disease in the community: a randomized controlled trial.

Authors:  Brendan J Barrett; Amit X Garg; Ron Goeree; Adeera Levin; Anita Molzahn; Claudio Rigatto; Joel Singer; George Soltys; Steven Soroka; Dieter Ayers; Patrick S Parfrey
Journal:  Clin J Am Soc Nephrol       Date:  2011-05-26       Impact factor: 8.237

6.  Racial differences in hepatitis C treatment eligibility.

Authors:  Michael T Melia; Andrew J Muir; Jonathan McCone; Mitchell L Shiffman; John W King; Steven K Herrine; Greg W Galler; Joseph R Bloomer; Frederick A Nunes; Kimberly A Brown; Kevin D Mullen; Natarajan Ravendhran; Reem H Ghalib; Navdeep Boparai; Ruiyun Jiang; Stephanie Noviello; Clifford A Brass; Janice K Albrecht; John G McHutchison; Mark S Sulkowski
Journal:  Hepatology       Date:  2011-07       Impact factor: 17.425

7.  Kidney dysfunction and cognitive decline in women.

Authors:  Imran Sajjad; Francine Grodstein; Jae H Kang; Gary C Curhan; Julie Lin
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-12       Impact factor: 8.237

8.  Honokiol ameliorates renal fibrosis by inhibiting extracellular matrix and pro-inflammatory factors in vivo and in vitro.

Authors:  Chih-Kang Chiang; Meei-Ling Sheu; Yi-Wei Lin; Cheng-Tien Wu; Chin-Ching Yang; Min-Wei Chen; Kuan-Yu Hung; Kuan-Dun Wu; Shing-Hwa Liu
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

9.  Comparison of chronic kidney disease prevalence examined by the chronic kidney disease epidemiology collaboration equation with that by the modification of diet in renal disease equation in Korean adult population.

Authors:  Sang-Yong Shin; Min-Jung Kwon; Hyosoon Park; Hee-Yeon Woo
Journal:  J Clin Lab Anal       Date:  2014-02-27       Impact factor: 2.352

10.  Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease.

Authors:  Simona Granata; Gianluigi Zaza; Simona Simone; Gaetano Villani; Dominga Latorre; Paola Pontrelli; Massimo Carella; Francesco Paolo Schena; Giuseppe Grandaliano; Giovanni Pertosa
Journal:  BMC Genomics       Date:  2009-08-21       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.